# Pineapple Financial Inc.: overview PAPL · NYSE · CIK 1938109 · [Financials](/sectors/financials.md) Pages: [Overview](/companies/papl.md) · [Financials](/companies/papl/financials.md) · [Filings](/companies/papl/filings.md) · [Insiders](/companies/papl/insiders.md) Latest reported revenue: [$622.5k](/filings/0001493152-26-033926.md) for Q3 FY2026, three months to 2026-05-31, from the 10-Q filed Jul 20, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-033926). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [718 d](/filings/0001493152-25-025962.md) | [766](/filings/0001493152-26-002942.md) | [743](/filings/0001493152-26-016374.md) | [747](/filings/0001493152-26-033926.md) | [727 d](/filings/0001493152-25-025962.md) | [722](/filings/0001493152-26-002942.md) | [707](/filings/0001493152-26-016374.md) | [623](/filings/0001493152-26-033926.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(191.5%) d](/filings/0001493152-25-025962.md) | [(90.5%)](/filings/0001493152-26-002942.md) | [(80.6%)](/filings/0001493152-26-016374.md) | [(93.3%)](/filings/0001493152-26-033926.md) | [(131.7%) d](/filings/0001493152-25-025962.md) | [(909.1%)](/filings/0001493152-26-002942.md) | [(2518.8%)](/filings/0001493152-26-016374.md) | [4005.4%](/filings/0001493152-26-033926.md) | | Net margin | % | [(240.1%) d](/filings/0001641172-25-019521.md) | [(85.7%)](/filings/0001493152-26-002942.md) | [(80.1%)](/filings/0001493152-26-016374.md) | [(74.7%)](/filings/0001493152-26-033926.md) | [(250.8%) d](/filings/0001493152-25-025962.md) | [(891.6%)](/filings/0001493152-26-002942.md) | [(2756.2%)](/filings/0001493152-26-016374.md) | [4056.2%](/filings/0001493152-26-033926.md) | | Diluted EPS | $ per share | not reported | [(2.60)](/filings/0001493152-26-002942.md) | [(1.73)](/filings/0001493152-26-016374.md) | [(0.93)](/filings/0001493152-26-033926.md) | not reported | [(4.79)](/filings/0001493152-26-002942.md) | [(1.21)](/filings/0001493152-26-016374.md) | [0.99](/filings/0001493152-26-033926.md) | | Free cash flow | $k | [(265) d](/filings/0001493152-25-025962.md) | not reported | not reported | not reported | not reported | [(492)](/filings/0001493152-26-002942.md) | [(3,273) d](/filings/0001493152-26-016374.md) | [(859) d](/filings/0001493152-26-033926.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-08-31) | FY2023 (2023-08-31) | FY2024 (2024-08-31) | FY2025 (2025-08-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $k | [3,601](/filings/0001493152-23-044927.md) | [2,502](/filings/0001493152-24-051101.md) | [2,689](/filings/0001493152-25-025962.md) | [2,987](/filings/0001493152-25-025962.md) | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | [(111.2%)](/filings/0001493152-24-051101.md) | [(142.2%)](/filings/0001493152-25-025962.md) | [(98.7%)](/filings/0001493152-25-025962.md) | | Net margin | % | [(78.0%)](/filings/0001493152-23-044927.md) | [(112.3%)](/filings/0001493152-24-051101.md) | [(152.6%)](/filings/0001493152-25-025962.md) | [(121.8%)](/filings/0001493152-25-025962.md) | | Diluted EPS | $ per share | [(0.45)](/filings/0001493152-23-044927.md) | [(0.45)](/filings/0001493152-24-051101.md) | [(11.46)](/filings/0001493152-25-025962.md) | [(5.31)](/filings/0001493152-25-025962.md) | | Free cash flow | $k | [(2,084)](/filings/0001493152-23-044927.md) | [(2,178)](/filings/0001493152-24-051101.md) | [(1,713)](/filings/0001493152-25-025962.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/papl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $50.4k | 49,938 | | Added +25,955 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $46.6k | 46,167 | | New +46,167 | | [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $32.6k | 23,000 | | New +23,000 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $20.9k | 20,728 | | New +20,728 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $8.4k | 8,333 | | Added +3,817 | | [TD Waterhouse Canada Inc.](/funds/1999606.md) | 2026-06-30 | $1.3k | 1,305 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $544 | 539 | | Unchanged | ## Recent filings [All 170 filings](/companies/papl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 13:26 ET | [8-K](/filings/0001493152-26-047167.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047167 | | 2026-07-20 | 20:52 ET | [10-Q](/filings/0001493152-26-033926.md) | Quarterly report, period 2026-05-31 | 0001493152-26-033926 | | 2026-06-03 | 20:05 ET | [8-K](/filings/0001493152-26-027046.md) | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027046 | | 2026-04-22 | 21:00 ET | [8-K](/filings/0001493152-26-018582.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018582 | | 2026-04-13 | 20:30 ET | [10-Q](/filings/0001493152-26-016374.md) | Quarterly report, period 2026-02-28 | 0001493152-26-016374 | | 2026-03-18 | 20:56 ET | [8-K](/filings/0001493152-26-011274.md) | 5.07 Shareholder vote results | 0001493152-26-011274 | | 2026-02-10 | 21:56 ET | [8-K](/filings/0001493152-26-005987.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-005987 | | 2026-02-06 | 23:54 ET | [DEF 14A](/filings/0001493152-26-005408.md) | Proxy statement, period 2026-02-05 | 0001493152-26-005408 | | 2026-01-21 | 23:43 ET | [10-Q](/filings/0001493152-26-002942.md) | Quarterly report, period 2025-11-30 | 0001493152-26-002942 | | 2026-01-05 | 21:05 ET | [SCHEDULE 13D](/filings/0001493152-26-000376.md) | Ownership report, active investor | 0001493152-26-000376 | ## Latest annual report [Form 10-K for the fiscal year ended Aug 31, 2025](/filings/0001493152-25-025962.md), filed Dec 3, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-08-31, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/09e46e01-a4dd-49b7-8d70-57cd40909e50) ## About the filer - CIK: 1938109 - Tickers: PAPL - Exchange: NYSE - SIC code: 6199 Finance Services - State of incorporation: A1 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.